The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation

• Beatrijs Mertens,
• Joost Wauters,
• Yves Debaveye,
• Niels Van Regenmortel,
• Karlien Degezelle,
• Philippe Meersseman,
• Greet Hermans,
• Christophe Vandenbriele,
• Ruth Van Daele,
• Isabel Spriet

Affiliations

Beatrijs Mertens

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven

Joost Wauters

Department of Microbiology, Immunology and Transplantation, KU Leuven

Yves Debaveye

Department of Cellular and Molecular Medicine, KU Leuven

Niels Van Regenmortel

Department of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg

Karlien Degezelle

Department of Perfusion Technology, University Hospitals Leuven

Philippe Meersseman

Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven

Greet Hermans

Medical Intensive Care Unit, University Hospitals Leuven

Christophe Vandenbriele

Department of Cardiovascular Diseases, University Hospitals Leuven

Ruth Van Daele

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven

Isabel Spriet

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven